Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer

被引:156
作者
Peralta, EA
Ellenhorn, JDI
Wagman, LD
Dagis, A
Andersen, JS
Chu, DZJ
机构
[1] City Hope Natl Med Ctr, Dept Gen & Oncol Surg, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Plast & Reconstruct Surg, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Biostat & Informat Sci, Duarte, CA 91010 USA
关键词
D O I
10.1016/S0002-9610(00)00505-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Risk factors for contralateral breast cancer (CBC) may indicate a benefit for contralateral prophylactic mastectomy (CPM) at the time of unilateral mastectomy for breast cancer. The purpose of this study is to evaluate the efficacy of CPM in preventing CBC. METHODS: sixty-four patients undergoing CPM and a control group of 182 patients not undergoing CPM and matched for age, stage, surgery, chemotherapy, and hormonal therapy were retrospectively compared for CBC rate, disease-free survival, and overall survival. RESULTS: Thirty-six CBCs Occurred in the control group. In the CPM group, 3 CBCs were found at the time of prophylactic mastectomy, but none occurred subsequently (P = 0.005). Disease-free survival at 15 years in the CPM group was 55% (95% confidence interval [CI] 38% to 69%) versus 28% (95% CI 19% to 36%) in the control group (P = 0.01). Overall survival at 15 years was 64% (95% CI 45% to 78%) CPM versus 48% (95% Ct 39% to 58%) in controls (P = 0.26). CONCLUSIONS: CPM prevented CBC and significantly prolonged disease-free survival. Future studies will need to address risk assessment and contralateral breast cancer prevention in patients treated for early breast cancer. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 21 条
[1]   RESULTS OF THE CANCER-RESEARCH CAMPAIGN ADJUVANT TRIAL FOR PERIOPERATIVE CYCLOPHOSPHAMIDE AND LONG-TERM TAMOXIFEN IN EARLY BREAST-CANCER REPORTED AT THE 10TH YEAR OF FOLLOW-UP [J].
BAUM, M ;
HOUGHTON, J ;
RILEY, D ;
MACINTYRE, J ;
BERSTOCK, D ;
MCKINNA, A ;
JACKSON, I ;
SAINSBURY, JRC ;
WILSON, A ;
WHEELER, T ;
DOBBS, J ;
REES, G ;
POWLES, T ;
RUBENS, R ;
HAYBRITTLE, J ;
MCPHERSON, K ;
HOUGHTON, J .
ACTA ONCOLOGICA, 1992, 31 (02) :251-257
[2]   THE WOMAN AT INCREASED RISK FOR BREAST-CANCER - EVALUATION AND MANAGEMENT STRATEGIES [J].
BILIMORIA, MM ;
MORROW, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (05) :263-278
[3]   Patient regrets after bilateral prophylactic mastectomy [J].
Borgen, PI ;
Hill, ADK ;
Tran, KN ;
Van Zee, KJ ;
Massie, MJ ;
Payne, D ;
Biggs, CG .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (07) :603-606
[4]   CONTRALATERAL BREAST-CANCER - ANNUAL INCIDENCE AND RISK PARAMETERS [J].
BROET, P ;
DELAROCHEFORDIERE, A ;
SCHOLL, SM ;
FOURQUET, A ;
MOSSERI, V ;
DURAND, JC ;
POUILLART, P ;
ASSELAIN, B .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1578-1583
[5]   Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer [J].
Chabner, E ;
Nixon, A ;
Gelman, R ;
Hetelekidis, S ;
Recht, A ;
Bornstein, B ;
Connolly, J ;
Schnitt, S ;
Silver, B ;
Manola, J ;
Harris, J ;
Garber, J .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2045-2051
[6]  
Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO
[7]  
2-Z
[8]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[9]  
2-B
[10]  
*EARL BREAST CANC, 1992, LANCET, V339, P1